ReposiTrak (NYSE:TRAK) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of ReposiTrak (NYSE:TRAK) from a hold rating to a buy rating in a report released on Saturday morning.

Separately, Weiss Ratings restated a “hold (c+)” rating on shares of ReposiTrak in a research report on Monday, December 8th. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, ReposiTrak presently has an average rating of “Hold”.

ReposiTrak Trading Down 2.8%

Shares of TRAK opened at $13.03 on Friday. ReposiTrak has a 12 month low of $12.75 and a 12 month high of $25.01. The firm’s 50 day moving average is $14.36 and its 200-day moving average is $16.76. The stock has a market capitalization of $238.32 million, a PE ratio of 36.19 and a beta of 0.39.

ReposiTrak (NYSE:TRAK) last issued its quarterly earnings results on Thursday, November 13th. The company reported $0.09 earnings per share (EPS) for the quarter. ReposiTrak had a return on equity of 14.37% and a net margin of 30.52%.The business had revenue of $5.97 million for the quarter.

Insider Activity

In related news, CEO Randall K. Fields sold 7,500 shares of the firm’s stock in a transaction on Monday, October 20th. The stock was sold at an average price of $15.47, for a total transaction of $116,025.00. Following the sale, the chief executive officer owned 35,000 shares of the company’s stock, valued at $541,450. This trade represents a 17.65% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders have sold 84,535 shares of company stock worth $1,255,765 in the last three months. 41.00% of the stock is currently owned by corporate insiders.

Institutional Trading of ReposiTrak

A number of hedge funds have recently made changes to their positions in the company. BNP Paribas Financial Markets raised its holdings in ReposiTrak by 63.5% in the 2nd quarter. BNP Paribas Financial Markets now owns 1,633 shares of the company’s stock valued at $32,000 after buying an additional 634 shares during the last quarter. Copeland Capital Management LLC acquired a new position in ReposiTrak in the 3rd quarter valued at approximately $54,000. Tower Research Capital LLC TRC raised its stake in shares of ReposiTrak by 397.3% during the second quarter. Tower Research Capital LLC TRC now owns 3,620 shares of the company’s stock valued at $71,000 after acquiring an additional 2,892 shares during the last quarter. GSA Capital Partners LLP acquired a new position in shares of ReposiTrak during the third quarter worth $219,000. Finally, R Squared Ltd acquired a new position in shares of ReposiTrak during the second quarter worth $235,000. 27.35% of the stock is owned by institutional investors and hedge funds.

ReposiTrak Company Profile

Park City Group, Inc, a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers.